The Research and Development Department includes three clusters of disease expert teams: NTD: Mycetoma and Leishmaniasis; NTD: Chagas, Filarial, and HAT; and Viral Diseases. Integrated Clinical Development Sciences (Drug Safety & Pharmacovigilance, Clinical Quality Assurance, and Translational Sciences), Regulatory Sciences, Clinical Operations, Discovery, and Pharmaceutical Development teams complement DNDi's R&D expertise. The department drives therapeutic innovation from the lab bench to the patient bedside, advancing DNDi's portfolio of treatment candidates from the outset (with the design of target product profiles) to the end point (enabling patients' access to new treatments).
Based anywhere in Africa, Europe and Latam
1st area